Regencell Bioscience
2 hedge funds and large institutions have $11.7K invested in Regencell Bioscience in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.
Holders
2
Holders Change
-2
Holders Change %
-50%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$6.53K |
Top Sellers
| 1 |
TRCT
1
Tower Research Capital (TRC)
New York
|
$0 |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$0 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $6.53K | +$87 | +152 | +1% |
|
2
BlackRock
New York
| $5.17K | – | – | – |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| – | -$5K | -7,600 | Closed |
|
|
4
UBS Group
Zurich,
Switzerland
| – | -$26 | -38 | Closed |
|